Use of MenAfriVac in a Controlled Temperature Chain (CTC) in Benin

February 12, 2013

This AMP, WHO, and PATH production presents the first campaign against meningitis A in Benin with MenAfriVac conjugate vaccine from November 15 to 25, 2012.

The use of a controlled temperature chain (CTC) meant that the vaccine could be used at ambient temperatures, outside the traditional cold chain (between 2°C and 8°C).